Research graph
References from Incidence and severity of SARS-CoV-2 infection in lung transplant recipients in the Omicron era. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
10.1016/s0140-6736(20)30566-3 · 2020 · External reference
High proportion of asymptomatic and presymptomatic COVID-19 infections in air passengers to Brunei
10.1093/jtm/taaa066 · 2020 · External reference
Mild or moderate Covid-19
10.1056/nejmcp2009249 · 2020 · External reference
Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-a Danish nationwide cohort study
10.1111/ajt.17142 · 2022 · External reference
The association between severe or death COVID-19 and solid organ transplantation: a systematic review and meta-analysis
10.1016/j.trre.2021.100628 · 2021 · External reference
Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network
10.1097/tp.0000000000003670 · 2021 · External reference
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic
10.1111/ajt.16840 · 2022 · External reference
Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: real-life data from Denmark
10.1111/ajt.17141 · 2022 · External reference
Trends in COVID-19 mortality among solid organ transplant recipients: implications for prevention
10.1097/tp.0000000000004170 · 2022 · External reference
COVID-19 in lung transplant recipients
10.1097/tp.0000000000003508 · 2021 · External reference
COVID-19 in lung transplant recipients: a multicenter study
10.1111/ajt.16364 · 2021 · External reference
The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: a multicenter experience
10.1016/j.healun.2022.06.011 · 2022 · External reference
COVID-19 in lung transplant recipients: an overview of the Swedish national experience
10.1111/tri.14148 · 2021 · External reference
COVID-19 vaccination is associated with favorable outcomes among lung transplant patients with breakthrough infections
10.1016/j.transproceed.2022.05.030 · 2022 · External reference
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
10.1016/s0140-6736(22)00941-2 · 2022 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Analyzing competing risk data using the R timereg package
10.18637/jss.v038.i02 · 2011 · External reference
Unresolved reference
External reference
Impact of omicron on lung transplant recipients: a third COVID-19 surge with different outcomes
10.1513/annalsats.202205-452rl · 2023 · External reference
COVID-19 clinical outcomes in solid organ transplant recipients during the omicron surge
10.1097/tp.0000000000004162 · 2022 · External reference
Outcomes of SARS-CoV-2 infection among lung transplant recipients: a single center retrospective study
10.1111/tid.14007 · 2023 · External reference
Clinical characteristics and outcomes of immunocompromised patients with coronavirus disease 2019 caused by the omicron variant: a prospective, observational study
10.1093/cid/ciac571 · 2023 · External reference
The importance of vaccination in the context of the COVID-19 pandemic: a brief update regarding the use of vaccines
10.3390/vaccines10040591 · 2022 · External reference
Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
10.3389/fimmu.2023.1120010 · 2023 · External reference
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection
2022 · External reference
Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study
10.1007/s15010-022-01914-8 · 2023 · External reference
Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipients
10.1111/tid.13967 · 2022 · External reference
Severe fatigue and persistent symptoms at 3 months following severe acute respiratory syndrome coronavirus 2 infections during the pre-delta, delta, and omicron time periods: a multicenter prospective cohort study
10.1093/cid/ciad045 · 2023 · External reference
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction
10.1093/cid/ciy1047 · 2019 · External reference
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant
10.1111/j.1600-6143.2005.00971.x · 2005 · External reference
Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study
10.1093/cid/ciaa1097 · 2021 · External reference
Efficacy of pre-exposure prophylaxis to prevent SARS-CoV-2 infection after lung transplantation: a two center cohort study during the omicron era
2023 · External reference
Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
10.1097/txd.0000000000001485 · 2023 · External reference
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave
10.1111/ajt.17199 · 2023 · External reference
